Professor Dr Muhammad Adnan Khattak
Board member KGC
Director Fiona Stanley hospital Clinical trial .... etc
Professor Dr Muhammad Adnan Khattak is a Medical Oncologist working at Fiona Stanley Hospital and Hollywood Private Hospital. He is also the Director at Fiona Stanley Hospital Cancer Clinical Trials Unit.
Background & Training
Dr Khattak did his initial specialist training at The Queen Elizabeth Hospital and Flinders Medical Centre in Adelaide before going to the UK. He worked as a Clinical Research Fellow at the Royal Marsden Hospital in London. He received his Fellowship in Medical Oncology in 2013 and started working as a Consultant at Royal Perth Hospital before transitioning to FSH in 2015.
Research, Publications
He has more than 100 publications at this stage in various peer-reviewed journals including the New England Journal of Medicine, the Lancet Oncology, JAMA Oncology, Journal of Clinical Oncology and European Journal of Cancer. He has also co-authored the National Health & Medical Research Council (NHMRC) guidelines for the management of advanced colorectal cancer.
He has presented his research at a number of National and International scientific meetings. He has been invited as a speaker to the US, Hong Kong, Taiwan, Saudi Arabia, Malaysia, China, Singapore and India.
He is the recipient of a number of prestigious research awards including Cancer Council WA Suzanne Cavanagh Young Investigator Award, Spinnaker Health Research Foundation Collaborative research grant, MSD Young Investigator award, NHMRC Developmental grant and Royal Perth Hospital Medical Research Foundation Award. He was also awarded the Raine Foundation translational research fellowship in 2019. He is the Chief Investigator/Associate Investigator of research grants in excess of A$3,000,000.
Clinical Trials
Dr Khattak is an active researcher, with interests in cancer immunotherapy. He is the the Primary Investigator of many International Clinical Trials. He is the pioneer of early drug development (Phase 1) work at Fiona Stanley Hospital and now leads one of the busiest trials unit in Perth.
